Activation of PKR by a short-hairpin RNA.
Double-stranded RNA
PKR
RNA interference
RNAi
dsRNA
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
09 10 2024
09 10 2024
Historique:
received:
14
05
2024
accepted:
26
09
2024
medline:
10
10
2024
pubmed:
10
10
2024
entrez:
9
10
2024
Statut:
epublish
Résumé
Recognition of viral infection often relies on the detection of double-stranded RNA (dsRNA), a process that is conserved in many different organisms. In mammals, proteins such as MDA5, RIG-I, OAS, and PKR detect viral dsRNA, but struggle to differentiate between viral and endogenous dsRNA. This study investigates an shRNA targeting DDX54's potential to activate PKR, a key player in the immune response to dsRNA. Knockdown of DDX54 by a specific shRNA induced robust PKR activation in human cells, even when DDX54 is overexpressed, suggesting an off-target mechanism. Activation of PKR by the shRNA was enhanced by knockdown of ADAR1, a dsRNA binding protein that suppresses PKR activation, indicating a dsRNA-mediated mechanism. In vitro assays confirmed direct PKR activation by the shRNA. These findings emphasize the need for rigorous controls and alternative methods to validate gene function and minimize unintended immune pathway activation.
Identifiants
pubmed: 39384561
doi: 10.1038/s41598-024-74477-3
pii: 10.1038/s41598-024-74477-3
doi:
Substances chimiques
eIF-2 Kinase
EC 2.7.11.1
RNA, Double-Stranded
0
EIF2AK2 protein, human
EC 2.7.11.1
RNA, Small Interfering
0
RNA-Binding Proteins
0
Adenosine Deaminase
EC 3.5.4.4
ADAR protein, human
EC 3.5.4.37
DEAD-box RNA Helicases
EC 3.6.4.13
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
23533Subventions
Organisme : NIH HHS
ID : K99MD016946
Pays : United States
Organisme : NIH HHS
ID : R35GM141262
Pays : United States
Organisme : National Institutes of Health, Pakistan
ID : R01CA262804
Informations de copyright
© 2024. The Author(s).
Références
Rehwinkel, J. & Gack, M. U. RIG-I-like receptors: their regulation and roles in RNA sensing. Nat. Rev. Immunol. 20, 537–551. https://doi.org/10.1038/s41577-020-0288-3 (2020).
doi: 10.1038/s41577-020-0288-3
pubmed: 32203325
pmcid: 7094958
Hovanessian, A. G. & Justesen, J. The human 2’-5’oligoadenylate synthetase family: unique interferon-inducible enzymes catalyzing 2’-5’ instead of 3’-5’ phosphodiester bond formation. Biochimie 89, 779–788. https://doi.org/10.1016/j.biochi.2007.02.003 (2007).
doi: 10.1016/j.biochi.2007.02.003
pubmed: 17408844
García, M. A., Meurs, E. F. & Esteban, M. The dsRNA protein kinase PKR: virus and cell control. Biochimie 89, 799–811. https://doi.org/10.1016/j.biochi.2007.03.001 (2007).
doi: 10.1016/j.biochi.2007.03.001
pubmed: 17451862
Cottrell, K. A., Andrews, R. J. & Bass, B. L. The competitive landscape of the dsRNA world. Mol. Cell 84, 107–119. https://doi.org/10.1016/j.molcel.2023.11.033 (2024).
doi: 10.1016/j.molcel.2023.11.033
pubmed: 38118451
Reich, D. P. & Bass, B. L. Mapping the dsRNA World. Cold Spring Harb. Perspect. Biol. https://doi.org/10.1101/cshperspect.a035352 (2019).
doi: 10.1101/cshperspect.a035352
pubmed: 30824577
pmcid: 6396333
Shang, R., Lee, S., Senavirathne, G. & Lai, E. C. microRNAs in action: Biogenesis, function and regulation. Nat. Rev. Genet. 24, 816–833. https://doi.org/10.1038/s41576-023-00611-y (2023).
doi: 10.1038/s41576-023-00611-y
pubmed: 37380761
pmcid: 11087887
Moore, C. B., Guthrie, E. H., Huang, M. T. & Taxman, D. J. Short hairpin RNA (shRNA): Design, delivery, and assessment of gene knockdown. Methods Mol. Biol. 629, 141–158. https://doi.org/10.1007/978-1-60761-657-3_10 (2010).
doi: 10.1007/978-1-60761-657-3_10
pubmed: 20387148
pmcid: 3679364
Birmingham, A. et al. 3’ UTR seed matches, but not overall identity, are associated with RNAi off-targets. Nat. Methods 3, 199–204. https://doi.org/10.1038/nmeth854 (2006).
doi: 10.1038/nmeth854
pubmed: 16489337
Jackson, A. L. et al. Widespread siRNA “off-target” transcript silencing mediated by seed region sequence complementarity. RNA 12, 1179–1187. https://doi.org/10.1261/rna.25706 (2006).
doi: 10.1261/rna.25706
pubmed: 16682560
pmcid: 1484447
Lewis, B. P., Burge, C. B. & Bartel, D. P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120, 15–20. https://doi.org/10.1016/j.cell.2004.12.035 (2005).
doi: 10.1016/j.cell.2004.12.035
pubmed: 15652477
Meurs, E. F., Galabru, J., Barber, G. N., Katze, M. G. & Hovanessian, A. G. Tumor suppressor function of the interferon-induced double-stranded RNA-activated protein kinase. Proc. Natl. Acad. Sci. U S A 90, 232–236. https://doi.org/10.1073/pnas.90.1.232 (1993).
doi: 10.1073/pnas.90.1.232
pubmed: 7678339
pmcid: 45634
Pindel, A. & Sadler, A. The role of protein kinase R in the interferon response. J. Interferon Cytokine Res. 31, 59–70. https://doi.org/10.1089/jir.2010.0099 (2011).
doi: 10.1089/jir.2010.0099
pubmed: 21166592
Qiao, H. et al. Cell fate determined by the activation balance between PKR and SPHK1. Cell Death Differ. 28, 401–418. https://doi.org/10.1038/s41418-020-00608-8 (2021).
doi: 10.1038/s41418-020-00608-8
pubmed: 32801355
Ucci, J. W., Kobayashi, Y., Choi, G., Alexandrescu, A. T. & Cole, J. L. Mechanism of interaction of the double-stranded RNA (dsRNA) binding domain of protein kinase R with short dsRNA sequences. Biochemistry 46, 55–65. https://doi.org/10.1021/bi061531o (2007).
doi: 10.1021/bi061531o
pubmed: 17198375
Su, Q. et al. Tyrosine phosphorylation acts as a molecular switch to full-scale activation of the eIF2alpha RNA-dependent protein kinase. Proc. Natl. Acad. Sci. USA 103, 63–68. https://doi.org/10.1073/pnas.0508207103 (2006).
doi: 10.1073/pnas.0508207103
pubmed: 16373505
Galabru, J. & Hovanessian, A. Autophosphorylation of the protein kinase dependent on double-stranded RNA. J. Biol. Chem. 262, 15538–15544 (1987).
doi: 10.1016/S0021-9258(18)47759-9
pubmed: 3479429
Dey, M., Mann, B. R., Anshu, A. & Mannan, M. A. Activation of protein kinase PKR requires dimerization-induced cis-phosphorylation within the activation loop. J. Biol. Chem. 289, 5747–5757. https://doi.org/10.1074/jbc.M113.527796 (2014).
doi: 10.1074/jbc.M113.527796
pubmed: 24338483
Nanduri, S., Carpick, B. W., Yang, Y., Williams, B. R. & Qin, J. Structure of the double-stranded RNA-binding domain of the protein kinase PKR reveals the molecular basis of its dsRNA-mediated activation. EMBO J. 17, 5458–5465. https://doi.org/10.1093/emboj/17.18.5458 (1998).
doi: 10.1093/emboj/17.18.5458
pubmed: 9736623
pmcid: 1170871
Schmedt, C. et al. Functional characterization of the RNA-binding domain and motif of the double-stranded RNA-dependent protein kinase DAI (PKR). J. Mol. Biol. 249, 29–44. https://doi.org/10.1006/jmbi.1995.0278 (1995).
doi: 10.1006/jmbi.1995.0278
pubmed: 7776374
Husain, B., Mukerji, I. & Cole, J. L. Analysis of high-affinity binding of protein kinase R to double-stranded RNA. Biochemistry 51, 8764–8770. https://doi.org/10.1021/bi301226h (2012).
doi: 10.1021/bi301226h
pubmed: 23062027
Kim, Y. et al. PKR senses nuclear and mitochondrial signals by interacting with endogenous double-stranded RNAs. Mol. Cell 71, 1051-1063.e1056. https://doi.org/10.1016/j.molcel.2018.07.029 (2018).
doi: 10.1016/j.molcel.2018.07.029
pubmed: 30174290
Cottrell, K. A., Ryu, S., Torres, L. S., Schab, A. M. & Weber, J. D. Induction of viral mimicry upon loss of DHX9 and ADAR1 in breast cancer cells. bioRxiv https://doi.org/10.1101/2023.02.27.530307 (2023).
doi: 10.1101/2023.02.27.530307
pubmed: 37662237
pmcid: 10002699
Kung, C. P. et al. Evaluating the therapeutic potential of ADAR1 inhibition for triple-negative breast cancer. Oncogene 40, 189–202. https://doi.org/10.1038/s41388-020-01515-5 (2021).
doi: 10.1038/s41388-020-01515-5
pubmed: 33110236
Nicholson, D. W. et al. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376, 37–43. https://doi.org/10.1038/376037a0 (1995).
doi: 10.1038/376037a0
pubmed: 7596430
Lazebnik, Y. A., Kaufmann, S. H., Desnoyers, S., Poirier, G. G. & Earnshaw, W. C. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 371, 346–347. https://doi.org/10.1038/371346a0 (1994).
doi: 10.1038/371346a0
pubmed: 8090205
Cottrell, K. A. et al. Induction of viral mimicry upon loss of DHX9 and ADAR1 in breast cancer cells. Cancer Res. Commun. 4, 986–1003. https://doi.org/10.1158/2767-9764.CRC-23-0488 (2024).
doi: 10.1158/2767-9764.CRC-23-0488
pubmed: 38530197
pmcid: 10993856
Safran, S. A., Eckert, D. M., Leslie, E. A. & Bass, B. L. PKR activation by noncanonical ligands: a 5’-triphosphate requirement versus antisense contamination. RNA 25, 1192–1201. https://doi.org/10.1261/rna.071910.119 (2019).
doi: 10.1261/rna.071910.119
pubmed: 31239298
pmcid: 6800522
Kostura, M. & Mathews, M. B. Purification and activation of the double-stranded RNA-dependent eIF-2 kinase DAI. Mol. Cell Biol. 9, 1576–1586. https://doi.org/10.1128/mcb.9.4.1576-1586.1989 (1989).
doi: 10.1128/mcb.9.4.1576-1586.1989
pubmed: 2725516
pmcid: 362574
Liu, H. et al. Tumor-derived IFN triggers chronic pathway agonism and sensitivity to ADAR loss. Nat. Med. 25, 95–102. https://doi.org/10.1038/s41591-018-0302-5 (2019).
doi: 10.1038/s41591-018-0302-5
pubmed: 30559422
Ishizuka, J. J. et al. Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade. Nature 565, 43–48. https://doi.org/10.1038/s41586-018-0768-9 (2019).
doi: 10.1038/s41586-018-0768-9
pubmed: 30559380
Gannon, H. S. et al. Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells. Nat. Commun. 9, 5450. https://doi.org/10.1038/s41467-018-07824-4 (2018).
doi: 10.1038/s41467-018-07824-4
pubmed: 30575730
pmcid: 6303303
Murayama, T. et al. Targeting DHX9 triggers tumor-intrinsic interferon response and replication stress in small cell lung cancer. Cancer Discov. 14, 468–491. https://doi.org/10.1158/2159-8290.CD-23-0486 (2024).
doi: 10.1158/2159-8290.CD-23-0486
pubmed: 38189443
pmcid: 10905673
Zhang, Z., Weinschenk, T., Guo, K. & Schluesener, H. J. siRNA binding proteins of microglial cells: PKR is an unanticipated ligand. J. Cell Biochem. 97, 1217–1229. https://doi.org/10.1002/jcb.20716 (2006).
doi: 10.1002/jcb.20716
pubmed: 16315288
Sledz, C. A., Holko, M., de Veer, M. J., Silverman, R. H. & Williams, B. R. Activation of the interferon system by short-interfering RNAs. Nat. Cell Biol. 5, 834–839. https://doi.org/10.1038/ncb1038 (2003).
doi: 10.1038/ncb1038
pubmed: 12942087
Armstrong, M. E. et al. Small interfering RNAs induce macrophage migration inhibitory factor production and proliferation in breast cancer cells via a double-stranded RNA-dependent protein kinase-dependent mechanism. J. Immunol. 180, 7125–7133. https://doi.org/10.4049/jimmunol.180.11.7125 (2008).
doi: 10.4049/jimmunol.180.11.7125
pubmed: 18490711
Puthenveetil, S. et al. Controlling activation of the RNA-dependent protein kinase by siRNAs using site-specific chemical modification. Nucleic Acids Res. 34, 4900–4911. https://doi.org/10.1093/nar/gkl464 (2006).
doi: 10.1093/nar/gkl464
pubmed: 16982647
pmcid: 1635244
Marques, J. T. et al. A structural basis for discriminating between self and nonself double-stranded RNAs in mammalian cells. Nat. Biotechnol. 24, 559–565. https://doi.org/10.1038/nbt1205 (2006).
doi: 10.1038/nbt1205
pubmed: 16648842
Mayo, C. B., Wong, C. J., Lopez, P. E., Lary, J. W. & Cole, J. L. Activation of PKR by short stem-loop RNAs containing single-stranded arms. RNA 22, 1065–1075. https://doi.org/10.1261/rna.053348.115 (2016).
doi: 10.1261/rna.053348.115
pubmed: 27208315
pmcid: 4911914
Kaempfer, R. Interferon-gamma mRNA attenuates its own translation by activating PKR: a molecular basis for the therapeutic effect of interferon-beta in multiple sclerosis. Cell Res. 16, 148–153. https://doi.org/10.1038/sj.cr.7310020 (2006).
doi: 10.1038/sj.cr.7310020
pubmed: 16474427
Heinicke, L. A. et al. RNA dimerization promotes PKR dimerization and activation. J. Mol. Biol. 390, 319–338. https://doi.org/10.1016/j.jmb.2009.05.005 (2009).
doi: 10.1016/j.jmb.2009.05.005
pubmed: 19445956
pmcid: 2763119
Zuker, M. Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res. 31, 3406–3415 (2003).
doi: 10.1093/nar/gkg595
pubmed: 12824337
pmcid: 169194